| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 42.347 | 39.770 | 19.872 | 17.698 | 8.463 | 8.463 | 4.192 | 0 | 0 | 0 |
| Total Income - EUR | 45.566 | 39.805 | 20.006 | 18.253 | 8.475 | 8.463 | 288.891 | 4.260 | 0 | 1 |
| Total Expenses - EUR | 373.058 | 107.916 | 60.042 | 27.828 | 17.842 | 14.446 | 226.764 | 1.451 | 66 | 67 |
| Gross Profit/Loss - EUR | -327.492 | -68.110 | -40.035 | -9.575 | -9.367 | -5.984 | 62.127 | 2.809 | -66 | -66 |
| Net Profit/Loss - EUR | -328.859 | -69.305 | -40.637 | -10.122 | -9.621 | -6.237 | 53.460 | 2.681 | -66 | -66 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pharmasud Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 336.658 | 305.175 | 284.111 | 264.059 | 244.678 | 229.001 | 1.006 | 0 | 0 | 0 |
| Current Assets | 219.702 | 108.156 | 80.204 | 82.873 | 85.249 | 87.962 | 88.174 | 85.335 | 85.010 | 84.469 |
| Inventories | 25 | 24 | 24 | 23 | 23 | 23 | 22 | 22 | 22 | 0 |
| Receivables | 206.695 | 73.740 | 75.599 | 82.599 | 84.773 | 87.506 | 87.905 | 84.628 | 84.371 | 83.900 |
| Cash | 12.983 | 3.188 | 4.581 | 251 | 453 | 434 | 247 | 685 | 617 | 570 |
| Shareholders Funds | -1.368.454 | -1.423.802 | -1.440.345 | -1.424.035 | -1.406.078 | -1.385.659 | -1.301.471 | -1.302.827 | -1.298.943 | -1.291.749 |
| Social Capital | 8.999 | 8.907 | 8.756 | 8.596 | 8.429 | 8.269 | 8.086 | 8.111 | 8.087 | 8.041 |
| Debts | 1.924.855 | 1.837.177 | 1.804.660 | 1.770.967 | 1.736.005 | 1.702.622 | 1.390.651 | 1.388.162 | 1.383.953 | 1.376.218 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Pharmasud Srl